BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

The Week In Review: Biotech In Positive Territory For 2007


4/9/2007 3:08:27 PM

April 8, 2007 -- Biotech had a very positive week. Over the four sessions, the Centient Biotech 200™ rose 116 points to 3995, a 3% climb. That puts biotech back in the black for 2007 with a gain of 1.8% since the first of the year. Breadth was very solid, even when measured against a 3% rise in the index. Simcere, a Chinese maker of generic drugs for its home market, set terms for its IPO. Corcept led the list of biotech companies higher with a gain of 55% after it raised new cash; Bioveris also booked a 55% rise on a buyout offer; Dendreon continued to climb on the FDA recommendation for Provenge; Encysive received permission to market Thelin in Ireland, and Antigenics rose after Dendreon increased the prospects for cancer immunotherapies. More details...


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES